in vivo News and Research

RSS

Norwegian scientists discover new small molecule drug to treat prostate cancer

Professor Fahri Saatcioglu at University of Oslo's Department of Biosciences (IBV) heads a research group investigating how androgens - male sex hormones - affect the risk of being affected by prostate cancer.

24 Jan 2019

Graphene Flagship project studies impact of graphene and related materials on our health

As the drive to commercialize graphene continues, it is important that all safety aspects are thoroughly researched and understood.

22 Jan 2019

Study reveals potential pathway for endothelial cells to avoid apoptosis

Cell death is an important aspect of tissue homeostasis, as well as inflammation and disease pathogenesis related to infection, injury, and tumor growth.

17 Jan 2019

Yeast model may pave way for development of novel therapies for metabolic disorders

There are hundreds of metabolic disorders -- including phenylketonuria, tyrosinemia, maple syrup urine disease and homocystinuria.

17 Jan 2019

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

From Charles River 16 Jan 2019

Reviewing applications of advanced materials in drug delivery and biomedicine

The Graphene family of materials has emerged as one of the most useful new age nano-biomaterials. Graphene-based materials exhibit excellent physicochemical properties, such as high electrical conductivity, mechanical strength, and high surface area with π-conjugated carbon atoms stacked to form honeycomb structure, suitable for binding other molecules.

11 Jan 2019

Sleep Research Society selects four outstanding scientists as recipients of 2019 SRS awards

The Sleep Research Society has selected four outstanding sleep and circadian scientists as recipients of the 2019 Sleep Research Society awards, which recognize excellence in sleep and circadian research.

11 Jan 2019

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

Millions of people suffer from inflammatory bowel disease worldwide, either in the form of ulcerative colitis or Crohn's disease, and few effective long-term treatments are available. Chronic intestinal inflammation is a hallmark of IBD.

9 Jan 2019

New “drug sponge” could reduce chemotherapy side effects

Researchers have developed a 3D polymer sponge that absorbs excess chemotherapy drugs from the bloodstream following treatment.

9 Jan 2019

Study: Rutin found in fruits and vegetables protect mice against snake venom

Rutin, a bioflavonoid found in certain vegetables and fruits, protects mice against snake venom by minimizing bleeding and inflammation, according to a study performed at the Butantan Institute, a research institution belonging to the government of São Paulo State in Brazil.

9 Jan 2019

FDA approves initiation of first-in-human trial of DNA-encoded monoclonal antibody

The Wistar Institute, along with partners Penn Medicine and Inovio Pharmaceuticals, Inc., announce that the FDA has approved the initiation of a first-in-human clinical trial investigating the safety and tolerability of a novel synthetic DNA-encoded monoclonal antibody therapeutic technology for the prevention of Zika virus infection.

9 Jan 2019

KU researcher studies how estrogen may protect menisci between thighbone and shinbone

More than 30 million Americans suffer from osteoarthritis of the knee, according to the Centers for Disease Control and Prevention.

9 Jan 2019

Pitt study delves deeper into how electrical stimulation activates neurons

Electrical stimulation of the brain is common practice in neuroscience research and is an increasingly common and effective clinical therapy for a variety of neurological disorders. However, there is limited understanding of why this treatment works at the neural level.

8 Jan 2019

Neuroscientists decipher how brain circuits optimize themselves

Human beings, like other animals, possess an enormous learning capacity that allows for the apprehension of new sensory information to master new skills or to adapt to an ever-changing environment.

2 Jan 2019

Scientists move one step closer towards treatment for low-grade gliomas with SYNODOS

Treatment for low-grade gliomas in patients living with neurofibromatosis type 1 are now one step closer thanks to recent research discoveries initiated and funded by the Children's Tumor Foundation.

28 Dec 2018

New review focuses on the structure-activity relationships of flavonoids

ABCB1 in the ABC transporter family also termed as P-glycoprotein, grants the simultaneous resistance of metastatic cancer cells towards various anti-cancer drugs with different targets and diverse chemical structures.

27 Dec 2018

New bacteria-based drug delivery system could radically expand cancer treatment options

An interdisciplinary team of three Virginia Tech faculty members affiliated with the Macromolecules Innovation Institute has created a drug delivery system that could radically expand cancer treatment options.

21 Dec 2018

New approach to destroy HIV reservoirs

Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Institut Pasteur scientists have identified the characteristics of CD4 T lymphocytes that are preferentially infected by the virus - it is their metabolic (or energy-producing) activity1 that enables the virus to multiply.

21 Dec 2018

Researchers find new way to cut the power of tumors

Instead of tackling tumors head-on, an international team of researchers from the University of Geneva and the Amsterdam UMC, location VUmc in Amsterdam has chosen to regulate their vascularization by intervening with cellular receptor that is overexpressed specifically in cancer blood vessels.

20 Dec 2018

Researchers synthesize new compound that inhibits replication of hepatitis C virus

A new compound that inhibits the replication of hepatitis C virus in several stages of its lifecycle - and is also capable of acting on bacteria, fungi and cancer cells - has been synthesized by researchers at São Paulo State University in Brazil.

19 Dec 2018

in vivo News and Research

Norwegian scientists discover new small molecule drug to treat prostate cancer

Graphene Flagship project studies impact of graphene and related materials on our health

Study reveals potential pathway for endothelial cells to avoid apoptosis

Yeast model may pave way for development of novel therapies for metabolic disorders

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Reviewing applications of advanced materials in drug delivery and biomedicine

Sleep Research Society selects four outstanding scientists as recipients of 2019 SRS awards

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

New “drug sponge” could reduce chemotherapy side effects

Study: Rutin found in fruits and vegetables protect mice against snake venom

FDA approves initiation of first-in-human trial of DNA-encoded monoclonal antibody

KU researcher studies how estrogen may protect menisci between thighbone and shinbone

Pitt study delves deeper into how electrical stimulation activates neurons

Neuroscientists decipher how brain circuits optimize themselves

Scientists move one step closer towards treatment for low-grade gliomas with SYNODOS

New review focuses on the structure-activity relationships of flavonoids

New bacteria-based drug delivery system could radically expand cancer treatment options

New approach to destroy HIV reservoirs

Researchers find new way to cut the power of tumors

Researchers synthesize new compound that inhibits replication of hepatitis C virus

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News